跳至主要内容
临床试验/ISRCTN63145981
ISRCTN63145981已完成4 期

Evaluation of the Efficacy of Artemisinin Combination Therapy in East Africa: A World Bank Multi-country East Africa Public Health Laboratory Networking Project. Rwanda Protocol

Rwanda Biomedical Centre0 个研究点目标入组 536 人开始时间: 2020年4月10日最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
536

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 1 to 14 years
  • 2. A slide-confirmed mono-infection of P. falciparum, asexual parasitemia between 1000 and 100000 p/ul
  • 3. Able to attend follow-up visits
  • 4. Written informed consent provided by parent or guardian. If the
  • parent/caretaker is illiterate, a witness’ signature and the
  • thumbprint of the participant’s parent/caretaker will be required.

排除标准

  • 1. Severe malnutrition
  • 2. Co-morbidity including but not limited to: infection, severe anaemia, epilepsy, abnormal cardiac rhythm, hypoglycemia, jaundice, respiratory distress, and recent history of allergy,
  • 3. Presence of danger signs including: an inability to drink, vomiting in the past 24 h, an axillary temperature of > 37.5°C or rectal/tympanic temp > 38.0°C, a history of fever within past 24 hours, and/or a recent history of multiple convulsions, unconsciousness, inability to stand or sit

研究者

相似试验